Exelixis (EXEL) EBT Margin (2010 - 2026)

Exelixis' (EXEL) quarterly EBT Margin came in at 43.82% in Q2 2026, up 679.0% year-on-year from 5.63% in Q2 2025, and up 3.83% quarter-over-quarter from 42.21% in Q1 2026.

Exelixis (EXEL) EBT Margin (2010 - 2026) Analysis & Trends

Exelixis' EBT Margin history runs 17 years deep, the most recent figure standing at 43.82% for Q2 2026.

  • On a quarterly basis, EBT Margin rose 679.0% year-over-year to 43.82% in Q2 2026; TTM through Apr 2026 was 42.23%, a 578.0% increase from a year earlier, with the FY2026 full-year figure at 40.57%, up 914.0% from the prior year.
  • EBT Margin advanced to 43.82% in Q2 2026 per EXEL's latest filing, from 42.21% in the prior quarter.
  • Across five years, EBT Margin topped out at 45.96% in Q2 2024 and bottomed at 7.41% in Q4 2022.
  • The 5-year median for EBT Margin is 23.94% (2022), against an average of 25.91%.
  • Biggest YoY gain for EBT Margin was 2890 bps in 2023; the steepest drop was 2112 bps in 2023.
  • Year by year, EBT Margin stood at 7.41% in 2022, then surged by 390 bps to 21.48% in 2023, then surged by 34 bps to 28.68% in 2024, then jumped by 47 bps to 42.23% in 2025, then climbed by 4 bps to 43.82% in 2026.
  • Per Business Quant, the three latest EXEL EBT Margin figures stand at 43.82% (Q2 2026), 42.21% (Q1 2026), and 42.23% (Q4 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 17.13%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 41.95%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.05%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 34.77%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Exelixis 14.38 Bn 13.60 Bn 590.86 Mn 43.82%

Historic Data

Download Data
DateValue
Apr 3, 2026 43.82%
Jan 2, 2026 42.21%
Oct 3, 2025 42.23%
Jul 4, 2025 40.55%
Apr 4, 2025 37.03%
Jan 3, 2025 32.60%
Sep 27, 2024 28.68%
Jun 28, 2024 45.96%
Mar 29, 2024 11.59%
Dec 29, 2023 21.48%
Sep 29, 2023 1.23%
Jun 30, 2023 21.37%
Mar 31, 2023 11.81%
Dec 30, 2022 -7.41%
Sep 30, 2022 22.35%
Jul 1, 2022 21.10%
Apr 1, 2022 23.94%
Oct 1, 2021 16.22%
Jul 2, 2021 32.42%
Apr 2, 2021 -0.75%